CLINICAL_TRIALS
trial_result
· 2023-01-25
Clinical Trial Update: A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE) [Phase 3]
Summary
Phase 3 trial of NI-071 in rheumatoid arthritis completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nichi-Iko Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2023-01-25